TP53 and Hyperglycemia: Our results showed that hyperglycemia reduced the functional activity of CHIP-stabilized phosphorylated p53, and that there was an increase in cell cycle arrest at G1 phase, indicating the loss of stemness that leads to the inability of stem cells to maintain their long-term undifferentiated state.